Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP)
This study has been withdrawn prior to enrollment.
(change of study population and chemotherapeutic regimen)
Merck Sharp & Dohme Corp.
Information provided by:
First received: January 31, 2007
Last updated: January 25, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||September 2008|
|Primary Completion Date:||No date given|